| Sepracor Inc. - [Ticker: SEPR]|| |
|Última Trade||Range 52 Semanas||[0,000 - 0,000]|
|Hora da Última Trade||N/A - N/A||Price-Target 1 Ano||N/A|
|Variação|| ()||Capitalização Bolsista||3 |
|Bid / Ask||N/A||EPS||0,00|
|Volume||Volume Médio (3m)||0|
|Nota: Os dados podem apresentar atraso de alguns minutos.|
|Ver cotações de outros activos|
|Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:|
|Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..|
| Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)|
Asthma Medication Market ? Global Industry Size, Growth Analysis, Trends, Demand and Segment Forecast To 2022Medgadget (blog)Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks ...e mais »
ContraFect (CFRX) Names Lisa Ricciardi as COOStreetInsider.com... firms and biotechnology companies. Ms. Ricciardi currently serves on the board United Drug Healthcare Group, PLC, and was a prior board member Chimerix Inc. as well as Sepracor Inc., which was sold to Dainippon Sumitomo for $2.6 billion.e mais »
Form 8-K Kala Pharmaceuticals, For: Sep 28StreetInsider.comOn September 28, 2017, the Board of Directors (the ?Board?) of Kala Pharmaceuticals, Inc. (the ?Company?) increased the size of the Board from eight to nine directors and, following the recommendation of the Nominating and Corporate Governance ...
Belgium's Ablynx enters the US marketPMLiVEAblynx Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market. Ablynx, Inc will be led by newly-appointed general manager Daniel Schneider, who will be based on the east coast.
Pediatric Internalizing Disorders: October 2017HealioAndrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...
Desloratadine Market Demand Analysis by Experts 2017 To 2022Otaku ReportsCompanies Profiled in this report includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...e mais »
|Para mais notícias sobre Sepracor Inc. clique aqui:|
Notícias de Sepracor Inc.